Subclassifications Of Assets, Liabilities And Equities [Abstract]

Hyloris Pharmaceuticals SA - Filing #5880972

Concept	As at 2024-12-31	As at 2023-12-31	As at 2022-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	340,000 EUR	429,000 EUR	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	3,838,000 EUR	3,828,000 EUR	—
Investments accounted for using equity method [abstract]
Investments accounted for using equity method	2,748,000 EUR	3,801,000 EUR	—
Trade and other non-current receivables [abstract]
Trade and other non-current receivables	2,050,000 EUR	1,591,000 EUR	—
Trade and other current receivables [abstract]
Trade and other current receivables	4,858,000 EUR	3,565,000 EUR	—
Cash and cash equivalents [abstract]
Cash and cash equivalents	23,594,000 EUR	30,406,000 EUR	33,457,000 EUR
Borrowings [abstract]
Non-current portion of non-current borrowings	1,489,000 EUR	1,510,000 EUR	—
Current borrowings and current portion of non-current borrowings [abstract]
Current borrowings	326,000 EUR	241,000 EUR	—
Non-current portion of non-current borrowings, by type [abstract]
Trade and other current payables [abstract]
Trade and other current payables	3,428,000 EUR	3,318,000 EUR	—
Issued capital [abstract]
Issued capital	140,000 EUR	140,000 EUR	—
Retained earnings [abstract]
Retained earnings, profit (loss) for reporting period	6,342,000 EUR	15,380,000 EUR	—
Retained earnings, excluding profit (loss) for reporting period	80,128,000 EUR	65,381,000 EUR	—
Miscellaneous equity [abstract]
Reserve of share-based payments	944,000 EUR	2,161,000 EUR	—
Net assets (liabilities) [abstract]
Assets	41,335,000 EUR	47,681,000 EUR	—
Liabilities	9,192,000 EUR	8,613,000 EUR	—
Net current assets (liabilities) [abstract]
Current assets	29,707,000 EUR	35,308,000 EUR	—
Current liabilities	7,162,000 EUR	6,759,000 EUR	—
Assets less current liabilities [abstract]